Abstract: Climacostol is a defense toxin produced by the ciliated protozoan Climacostomum virens and belongs to resorcinolic lipids, a group of compounds that shows antimicrobial, antiparasitic, and cytotoxic activities. In this study we investigate the antimicrobial activity of climacostol and its alkyl and alkynyl derivatives against a panel of bacterial and fungal pathogens. Our results show a good and comparable antimicrobial activity of the three compounds, which have resulted effective against Gram-positive bacteria and Candida with MIC and MBC ranging from 8 to 32 mg L −1 , whereas no significant effect against Gram-negative species has been observed. Taken as a whole, the experimental data reported in the current study suggest that differences in the saturation rate of the lateral chain of climacostol are not related to the activity of the molecule. Therefore, it is likely that the general structure of the two moieties, i.e., the di-hydroxy-phenyl group and the alkenyl chains, contributes to the overall antibiotic behaviour.
Introduction
As recently outlined by Da Rocha et al. (2001) , about 60% of approved pharmaceutical agents are derived from natural compounds, by screening plants, animals, fungi, and microorganisms, confirming that nature is an extremely rich source of highly diverse and innovative chemical structures. Among the variety of natural compounds, secondary metabolites have repeatedly attracted the attention of researchers for their interesting biological activities and, sometimes, for their desirable pharmacological profiles. In particular, eukaryotic microorganisms, such as protozoa and microalgae, most of which were previously ignored, have now come into focus as important new sources of bioactive secondary metabolites.
A dozen of secondary metabolites has to date been isolated from ciliated protozoa, and many of these molecules seem to be the result of evolutionary selection related to defense and/or predatory mechanisms. These substances include keronopsin isolated from Pseudokeronopsis rubra Ehrenberg, 1836 (Höfle et al. 1994) , euplotins (Dini et al. 1993; Guella et al. 1994) , raikovenal (Guella et al. 1995; Rosini et al. 1998 ) and epoxyfocardin (Guella et al. 1996) from Euplotes species, blepharismin from Blepharisma japonicum Suzuki, 1954 (Gioffrè et al. 1993 Checcucci et al. 1997) , stentorin from Stentor coeruleus Ehrenberg, 1830 (Tao et al. 1993; Cameron et al. 1995) , spirostomin from Spirostomum teres Claparede et Lachmann, 1858 (Sera et al. 2006 , maristentorin from Maristentor dinoferus Lobban et al., 2002 (Mukherjiee et al. 2006 , climacostol from Climacostomum virens Ehrenberg, 1833 (Miyake et al. 2003) , and monoprenyl-hydroquinone from Spirostomum ambiguum Ehrenberg, 1835 (Buonanno et al. 2012 ). Interestingly, due to its antimicrobial and pro-apoptotic activity in some tumor cell lines, the sesquiterpenoid euplotin C was recently proposed for the design of new drugs (Savoia et al. 2004; Cervia et al. 2006 Cervia et al. , 2007 . Antiviral and antibacterial activities were also reported for stentorin (Lobban et al. 2007) and blepharismin (Pant et al. 1997) , which are both derivatives of hypericin, i.e., a polycyclic aromatic compound extracted from plants of the genus Hypericum.
Climacostol [5-(Z)-non-2-enyl-benzene-1,3-diol] is a colorless toxin used by the freshwater ciliate C. virens for chemical defense against predators. The molecule belongs to a large group of natural compounds known as resorcinolic lipids (also called alkylresorcinols, or 5-alkylresorcinols), widely detected in plants, fungi, algae, and in one animal species, the marine sponge Haliclona sp. (Kozubek & Tyman 1999; Stasiuk & Kozubek 2010) . The common structural motif of resorcinolic lipids resides in the 1,3-dihydroxybenzene (resorcinol) unit bearing an alkyl or an alkenyl chain at 5-position of the aromatic ring. Many biologically active compounds belonging to this class of derivatives also include other functional groups in the aromatic ring as well as in the 526 D. Petrelli et al. alkyl chain. Antimicrobial, antiparasitic, anticancer and genotoxic activities have been reported to date for this group of compounds (Lytollis et al. 1995; Singh et al. 1995; Kozubek et al. 2001) .
Experimental data demonstrated that climacostol can specifically inhibit the respiratory chain complex I in rat liver mitochondria (Muto et al. 2011 ) and the growth of human tumor cell lines by triggering an apoptosis-like programmed cell death (Buonanno et al. 2008) .
In recent years climacostol has been chemically synthesized by two alternative pathways (Masaki et al. 1999 (Masaki et al. , 2004 Mori & Abe 2001) . In the approach adopted by Masaki et al. (2004) the alkynil (5-Non-2-ynyl-benzene-1,3-diol) and alkyl (5-Nonyl-benzene-1,3-diol) derivatives of climacostol were also synthesized, in order to evaluate their biological activity. compared the activity of climacostol and its derivatives against ten species of free-living unicellular eukaryotes and observed that the cytotoxic potential of the three compounds appeared strictly related to their molecular structures, with particular regard to the presence of a single, double or triple bond in the side chain.
The present paper describes the antimicrobial activity of climacostol and derivatives against a panel of bacterial and fungal pathogens.
Material and methods

Climacostol and its derivatives
Chemically synthesized climacostol (5-(Z)-non-2-enyl-benzene-1,3-diol) and its two derivatives (5-nonylbenzene-1,3-diol and 5-non-2-ynyl-benzene-1,3-diol) were kindly provided by Dr. Marcantoni and Dr. Iio (see "Acknowledgements"). The compounds (Fig. 1) were dissolved in ethanol (5 mg ml −1 ) and stored in the dark at -80
• C. The solution was diluted with an appropriate medium at the time of the experiment.
Microorganisms Climacostol and derivatives were tested against a panel of microorganisms including Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis ATCC 35984, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Streptococcus pneumoniae ATCC 49619, Enterococcus faecalis ATCC 29212, Candida albicans ATCC 24433 and four ciprofloxacin-resistant Staphylococcus aureus clinical strains (SA019, SA040, SA047 and SA070) (Petrelli et al. 2008 ).
Antimicrobial activity
Minimum Inhibitory Concentrations (MICs) for climacostol and its two derivatives were determined by the broth microdilution method as recommended by Clinical Laboratory Standard Institute (CLSI 2009).
Twofold serial dilutions of each compound were prepared in 96-well plates, starting from 512 mg L −1 in Cation Adjusted Mueller Hinton Broth, Cation Adjusted Mueller Hinton Broth + 5% lysed Horse blood or RPMI 1640 medium, depending on the microorganism tested. An equal volume of bacterial inoculum (10 6 cfu ml −1 ), obtained by direct colony suspension of an overnight culture, was added to each well of the microtiter plate containing 0.1 ml of the serially diluted test molecule. After incubation for 18-24 h at 35
• C (24-48 h in case of Candida), in normal atmosphere (S. pneumoniae was in 5% CO2), MICs were determined as the lowest concentration of compound able to inhibit the growth of the microorganisms. All tests were done in triplicate. Minimum Bactericidal Concentration (MBC) was subsequently determined as recommended by the CLSI guidelines (CLSI 2009).
Results and discussion
The antimicrobial activity of climacostol and its derivatives against eight Gram-positive and two Gramnegative bacteria, and one fungus was determined as the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and the results are summarized in Table 1 . In general, a one-fold dilution difference in comparing either two compounds or two species has been considered as not significant. This interpretative criterion has been applied throughout the whole analysis.
The MICs measured for all compounds against the reference Staphylococcus aureus strain (ATCC 25923) were identical, with a value of 16 mg L −1 . Substantially identical antimicrobial activity values (8-16 mg L −1 ) were also measured for all the other ciprofloxacinresistant S. aureus strains.
The choice to test four quinolone-resistant isolates was suggested by the possible interaction of climacostol with the DNA (Buonanno et al. 2008; Fiorini et al. 2010 ). More in general, the ability to cleave DNA was repetitively reported for resorcinolic lipids. This is the case of 5-n-tridecyl and 5-n-pentadecenylresorcinols extracted from the plant Hakea sp., which exhibited the ability to induce Cu 2+ -dependant scission of the replicating strand in plasmid DNA φX174 (Stasiuk & Kozubek 2010) . Some authors also reported that several bis-dihydroxyalkylbenzenes are capable of mediating Cu 2+ -dependent DNA cleavage and strongly inhibiting DNA polymerase β. (Starck et al. 2000) . At the moment the mechanism of action of the title compounds in prokaryotes is not known, but our data clearly indicate that the mutations occurring in the DNA topoisomerases of the quinolone-resistant isolates do not interfere with the activity of climacostol and derivatives.
With regard to the other Gram-positive species examined in this work, we observed that the growth of Streptococcus pneumoniae and Enterococcus faecalis was inhibited at the same level by the three compounds, with MIC values from 8 to 16 mg L −1 . On the other hand, the effectiveness of 5-nonylbenzene-1,3-diol in inhibiting the growth of Staphylococcus epidermidis appeared slightly higher (MIC = 8 mg L −1 ) than that measured for climacostol and 5-non-2-ynyl-benzene-1,3-diol (MIC = 16-32 mg L −1 ). The three compounds were bactericidal against all the Gram-positive species considered (Table 1) . Similar to what observed for MICs, the lowest MBC against Staphylococcus epidermidis was measured for 5-nonylbenzene-1,3-diol (8 mg L −1 ), whereas a higher value (32 mg L −1 ) was measured for climacostol and 5-non-2-ynyl-benzene-1,3-diol.
The growth of the bacterial species representative of the Gram-negatives was not inhibited at a concentration lower than 256 mg L −1 . Only compound 5-nonylbenzene-1,3-diol showed a MIC of 128 mg L −1 against both E. coli and P. aeruginosa. However, this level of activity is not remarkable. Accordingly, all the MBCs were above the higher concentration tested. Hence, it can be concluded that climacostol and derivatives were not active against the two Gram-negative species examined.
The scarce effect observed for the three compounds against E. coli and P. aeruginosa can be explained by the peculiar structure of the Gram-negative bacterial cell wall. The outer membrane is indeed a selective barrier to the penetration of several compounds, due to the hydrophilic nature of the surface exposed to the environment and to the selectivity of the outer membrane proteins, i.e. the porins.
At last, the fungicidal activity against Candida albicans was assayed. Climacostol and derivatves were equally active against this species. The inhibition was achieved at 8 mg L −1 , which represents a good activity. The cytotoxic effect of the title compounds was previously investigated on 10 species of single-celled eukaryotes, for which the effectiveness of their biological activity appeared strictly related to saturation rate of the aliphatic chain of climacostol .
The results reported in the present study showed an essentially invariable antimicrobial activity of the three compounds. Therefore, it can be concluded that differences in the saturation rate of the lateral chain of climacostol appear not related with the activity of the molecule. Most probably the general structure of the two moieties, i.e. the di-hydroxy-phenyl group and the alkenyl chains, contributes to the overall antibiotic behaviour.
In conclusion, the low MIC values of climacostol and its derivatives against Gram-positives and C. albicans may set the basis for the development of a novel series of antimicrobial agents.
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